The justices unanimously upheld Monsanto’s patent rights on Roundup Ready seeds.
The Scientist
Most Recent
A decision will not be reached until later in the year, but the United States’ top justices appear to be inclined to rule against the validity of patenting human genes.
In an upcoming hearing, the US Supreme Court will decide on whether police can take DNA samples from suspects who have not been convicted.
The highest court in the country has declined to hear an appeal regarding the federal funding of human embryonic stem cell research, allowing such spending to continue.
Scientists fighting the federal funding of human embryonic stem cell research bring their case before the country’s highest court.
New Jersey judges are now required to explain to jurors that the human memory is prone to errors.
James Watson files a brief in the ongoing legal case over Myriad Genetics’ right to hold patents on the BRCA1 and BRCA2 genes.
The Supreme Court's decision to uphold President Barack Obama's health care reform law contains key provisions that will impact US science funding in the years to come.
The US Supreme Court ordered patents held by Myriad Genetics to be reviewed further by the Federal Circuit Court.
The US Supreme Court ruled that two dose calibration methods from biotech company Prometheus Laboratories cannot be patented.
Page 1 of 1
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
